Form 4: Guardant Health Executive Kumud Kalia Reports Stock Transactions
SEC Form 4 Filing
Guardant Health's Chief Information Officer, Kumud Kalia, executed stock transactions involving the vesting of restricted stock units and the sale of shares to cover tax obligations.
Summary
- Kumud Kalia, Chief Information Officer of Guardant Health, reported transactions involving company stock on January 1, 2025.
- These transactions included the vesting of 1,607 and 1,083 restricted stock units, which converted into common stock.
- A total of 1,103 shares were sold at $30.55 per share to cover tax obligations related to the vesting of the restricted stock units.
- Following these transactions, Kalia directly owns 19,995 shares of common stock and 18,836 restricted stock units.
Sentiment
Score: 7
Explanation: The document reflects routine executive stock transactions, which are neither particularly positive nor negative. The transactions are part of standard compensation practices.
Industry Context
This is a routine filing related to executive compensation and is common for publicly traded companies. It provides transparency into the stock transactions of company insiders.
Comparison to Industry Standards
- Stock-based compensation is a common practice in the technology and biotechnology industries, where Guardant Health operates.
- The vesting schedules and tax withholding practices described are typical for restricted stock unit awards.
- Other companies such as Illumina, Exact Sciences, and Adaptive Biotechnologies also use similar equity compensation plans for their executives.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect the standard vesting of executive compensation.
- The sale of shares to cover tax obligations is a common practice and does not indicate any negative sentiment from the executive.
Key Dates
| Date | Description |
|---|---|
| 11/07/2022 | Date of grant for a restricted stock unit award that vests over four years. |
| 12/13/2023 | Date of grant for a restricted stock unit award that vests over three years. |
| 10/01/2023 | First vesting date for the restricted stock unit award granted on November 7, 2022. |
| 10/01/2024 | First vesting date for the restricted stock unit award granted on December 13, 2023. |
| 01/01/2025 | Date of stock transactions including vesting of restricted stock units and sale of shares. |
| 01/03/2025 | Date of filing of the Form 4. |
Keywords
Guardant Health, stock transaction, restricted stock units, Form 4, insider trading, executive compensation, Kumud Kalia
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.